Elevated levels of BFL-1 have been observed in B-cell CLL, AML, MCL and primary mediastinal large B-cell lymphoma [73,74,75,76] and contribute to chemoresistance and disease progression. This evidence concerns the gene BCL2A1 and B-cell chronic lymphocytic leukemia.